Last reviewed · How we verify
Placebo of Dutasteride Capsule
This is a placebo control formulation containing no active pharmaceutical ingredient, used as a comparator in clinical trials.
At a glance
| Generic name | Placebo of Dutasteride Capsule |
|---|---|
| Sponsor | Chong Kun Dang Pharmaceutical |
| Modality | Small molecule |
| Phase | Phase 3 |
Mechanism of action
Placebos are inert substances administered in controlled trials to establish baseline efficacy and safety profiles of the active drug being tested. In this case, it is a placebo matching the capsule formulation of dutasteride, a 5-alpha reductase inhibitor, but without the active ingredient. The placebo allows researchers to distinguish true drug effects from placebo response and natural disease progression.
Approved indications
Common side effects
Key clinical trials
- Dutasteride Treatment for Reducing Heavy Drinking in AUD: Predictors of Efficacy (PHASE2, PHASE3)
- A Phase 3 Study to Evaluate the Safety and Efficacy of CKD-843 in Male Patients With Androgenetic Alopecia (PHASE3)
- Effect of Dutasteride on Androgen-Response Gene Expression in Patients With Advanced Prostate Cancer (PHASE2)
- Dutasteride to Treat Women With Menstrually Related Mood Disorders (PHASE1)
- Study to Compare the Efficacy and Safety of Combination Treatment With Dutasteride and Tamsulosin With Tamsulosin Monotherapy, in Men With Moderate to Severe Benign Prostatic Hyperplasia (PHASE3)
- Sexual Function in Men Receiving Dutasteride for Androgenetic Alopecia (PHASE3)
- Prospective Sexual Function Study for BPH Subjects (PHASE4)
- Dutasteride for the Reduction of Alcohol Use in Male Drinkers (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Placebo of Dutasteride Capsule CI brief — competitive landscape report
- Placebo of Dutasteride Capsule updates RSS · CI watch RSS
- Chong Kun Dang Pharmaceutical portfolio CI